Markets:

Overview

News

Currencies

International

Treasuries

GT Biopharma, Inc. - Common Stock (NQ:GTBP)

0.3081 +0.0023 (+0.75%)

Streaming Delayed Price Updated: 10:59 AM EDT, Aug 25, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GT Biopharma, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Which stocks are moving before the opening bell on Thursday? ↗

October 09, 2025

As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 09, 2025

Via Benzinga

Why Richardson Electronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket ↗

October 09, 2025

Via Benzinga

GT Biopharma Stock Logs Best Session In Over 9 Months On Promising Cancer Trial Data; Retail Eyes Double-Digit Rally ↗

October 08, 2025

Via Stocktwits

GTBP Stock Earnings: GT Biopharma Reported Results for Q2 2024 ↗

August 14, 2024

GT Biopharma just reported results for the second quarter of 2024.

Via InvestorPlace

What's going on in today's after hours session ↗

October 08, 2025

Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics.

Via Chartmill

Keep an eye on the top gainers and losers in Wednesday's session. ↗

October 08, 2025

Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

EXCLUSIVE: GT Biopharma Reports Progresses Phase 1 Trial Of Lead Drug Candidate For Blood Cancers ↗

October 08, 2025

GT Biopharma's Phase 1 trial of GTB-3650 progresses with early safety signals, immune activation, and plans to advance to higher dose cohorts into 2026.

Via Benzinga

Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion

October 06, 2025

EQNX::TICKER_START (NASDAQ:GTBP),(NASDAQ:LPTX),(NASDAQ:IOBT),(NASDAQ:CELC),(NYSE:MAIA) EQNX::TICKER_END

Via FinancialNewsMedia

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 10, 2025

Via Benzinga

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

September 08, 2025

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday.

Via Chartmill

Friday's after hours session: top gainers and losers ↗

September 05, 2025

After the conclusion of the US market's regular session on Friday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 20, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 08, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

July 07, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 03, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

June 06, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

June 03, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 21, 2025

Via Benzinga

EXCLUSIVE: GT Biopharma Advances Relapsed Blood Cancer Therapy Trial To Cohort 2 After Promising Early Safety Results ↗

May 19, 2025

GTBP announces completion of dosing in Cohort 1 and start of dosing in Cohort 2 of Phase 1 trial for GTB-3650, showing potential for NK cell expansion and increased immunologic activity. Detailed...

Via Benzinga

GT Biopharma Retail Chatter Soars Most Among Biotechs After Financing Strategy Tweak ↗

February 25, 2025

The company said it had withdrawn its earlier Form S-1 registration, initially filed with the SEC in December, which sought approval for an automatic mixed securities shelf offering.

Via Stocktwits

Topics Regulatory Compliance

Traders are paying attention to the gapping stocks in Tuesday's session. ↗

February 25, 2025

Traders are paying attention to the gapping stocks in Tuesday's session. Let's dive into which stocks are experiencing notable gaps.

Via Chartmill

What's going on in today's pre-market session ↗

February 25, 2025

Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 14, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 13, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 23, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 22, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 21, 2024

Via Benzinga

What's Going On With GT Biopharma Stock Tuesday? ↗

May 21, 2024

GT Biopharma entered into a definitive securities purchase agreement for the purchase and sale of 740,000 shares of its common stock at a purchase price of $4.35 per share. The shares will be offered...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

May 20, 2024

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.